Parkinson’s Disease Drugs Market 2020 Global Top Key Players

September 15, 2020
Ankit2369

The global Parkinson’s disease drugs market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson’s disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655

Detailed Table of Content:

 

  • Introduction

o    Research Scope

o    Market Segmentation

o    Research Methodology

o    Definitions and Assumptions

  • Executive Summary
  • Market Dynamics

o    Market Drivers

o    Market Restraints

o    Market Opportunities

o    Market Trends

  • Key Insights

o    Prevalence of Parkinson’s Disease – For Key Countreis, 2018

o    Regulatory Scenario – For Key Countries

o    Patent Snapshot

o    New Product Launch

o    Pipeline Analysis

o    Key Industry Developments – Mergers, Acquisitions and Partnerships

  • Global Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025

o    Key Findings / Summary

o    Market Analysis, Insights and Forecast – By Drug Class

  • Decarboxylase Inhibitors
  • Dopamine Agonists
  • Monoamine Oxidase Type B (MAO-B) Inhibitors
  • Catechol-O-Methyltransferase (COMT) Inhibitors
  • Others

o    Market Analysis, Insights and Forecast – By Route of Administration

  • Oral
  • Injection
  • Transdermal

o    Market Analysis, Insights and Forecast – By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Stores

o    Market Analysis, Insights and Forecast – By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • North America Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025

o    Key Findings / Summary

o    Market Analysis – By Drug Class

  • Decarboxylase Inhibitors
  • Dopamine Agonists
  • Monoamine Oxidase Type B (MAO-B) Inhibitors
  • Catechol-O-Methyltransferase (COMT) Inhibitors
  • Others

o    Market Analysis – By Route of Administration

  • Oral
  • Injection
  • Transdermal

o    Market Analysis – By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Stores

o    Market Analysis – By Country

  • U.S.
  • Canada

 

Article Categories:
HEALTH

Leave a Comment